Abstract
To examine the diagnostic work-up and subsequent management of patients with pulmonary embolism, we retrospectively reviewed the medical records of 60 patients who had arteriographically proven pulmonary embolism. Ventilation-perfusion scans were utilized in 47 patients and were classified as showing a high (55.3%), moderate (14.9%), low (8.5%), or indeterminate (21.3%) probability of pulmonary embolism. Of the 33 patients treated with anticoagulation, complications occurred in 10 (30.3%). Of the 39 patients treated with inferior vena cava filters, complications occurred in 16 (41.0%) patients, with the most clinically significant complication being recurrent pulmonary embolism, found to occur in one (2.6%) patient. For patients treated with anticoagulation, heparin was started an average of 0.3 (±0.5) days following the initial suspicion of a pulmonary embolism. The average time to reach a therapeutic partial thromboplastin time level was 2.0 (±1.8) days, and warfarin was started an average of 6.2 (±4.1) days after heparin was begun. Among the 60 patients, five (8.3%) died from the pulmonary embolism, and two of these had at least a five day delay before diagnosis was made by pulmonary arteriography. Since the ventilationperfusion scan had a sensitivity of 70.2% and a false negative rate of 8.5%, it is not always sufficiently accurate in making final treatment decisions, so there should be less hesitation in attaining pulmonary arteriograms. Therapeutic partial thromboplastin time levels should be more aggressively sought. Warfarin should be started within the first few days of heparin therapy. Inferior vena cava filters should be utilized in patients who have a contraindication to anticoagulation therapy or a complication from anticoagulation therapy.
Similar content being viewed by others
References
MOSER KM. Pulmonary embolism.Am Rev Respir Dis 1977;115:829–852.
MENZOIAN JO, WILLIAMS LF. Is pulmonary angiography essential for the diagnosis of acute pulmonary embolism?Am J Surg 1979;137(4):543–548.
MC BRIDE K, LA MORTE WW, MENZOIAN JO. Can V/Q scans accurately diagnose acute pulmonary embolism?Arch Surg 1986;121:754–757.
DALEN JE, ALPERT JS. Natural history of pulmonary embolism.Prog Cardvasc Dis 1975;17(4):259–270.
MILLS SR, JACKSON DC, OLDER RA, et al. The incidence, etiologies and avoidance of complications of pulmonary angiography in a large series.Radiology 1980;136:295–299.
PORTER J, HERSHEL J. Drug-related deaths among medical inpatients.JAMA 1977;237:879–882.
CARANASOS GJ, STEWART RB, CLUFF LE. Druginduced illness leading to hospitalization.JAMA 1974;228:713.
BELL WR, SIMON T. Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention and treatment.Am Heart J 1982;103(2):239–262.
ALPERT JS, SMITH R, CARLSON CJ, et al. Mortality in patients treated for pulmonary embolism.JAMA 1976;236(13):1477–1480.
GENTON E. Guidelines for heparin therapy.Ann Intern Med 1974;80:70–82.
WHEELER AP, JAQUISS RD, NEWMAN JH. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis.Arch Intern Med 1988;148(6):1321–1325.
ROSIELLO RA, CHAN CK, TENCZA F, et al. Timing of oral anticoagulation therapy in the treatment of angiographically proven acute pulmonary embolism.Arch Intern Med 1987;147(8):1469–1473.
GLENNY RW. Pulmonary embolism: complications of therapy.South Med J 1987;80(10):1266–1276.
POWERS PJ, KELTON JG, CARTER C. Studies on the frequency of heparin-associated thrombocytopenia.Thromb Res 1984;33:439–443.
BELL WR, ROYALL RM. Heparin-associated thrombocytopenia: a comparison of three heparin preparations.N Engl J Med 1980;303:907–909.
CHERNOFF A. Anaphylactic reactions following injection of heparin.N Engl J Med 1950;242:315.
BELL W, SIMON T. Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment.Am Heart J 1982;103:239–262.
ROHRER MJ, SCHEIDLER MG, WHEELER HB, et al. Extended indications for placement for an inferior vena cava filter.J Vasc Surg 1989;10:44–50.
CANTELMO NL, MENZOIAN JO, LOGERFO FW, et al. Clinical experience with vena caval filters in high-risk cancer patients.Cancer 1982;50:341–344.
OLIN JW, YOUNG JR, GRAOR RA, et al. Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors.Arch Intern Med 1987;147:2177–2179.
WOOLSON ST, HARRIS WH. Greenfield vena caval filter for management of selected cases of venous thromboembolic disease following hip surgery.Clin Ortho 1986;204:201–206.
GREENFIELD LJ, MICHNA BA. Twelve-year clinical experience with the Greenfield vena caval filter.Surgery 1988;104(4):706–711.
Author information
Authors and Affiliations
About this article
Cite this article
Israeli, D., Kalhorn, A. & Menzoian, J.O. Physician practices in the diagnosis and management of patients with pulmonary embolism. Annals of Vascular Surgery 5, 337–344 (1991). https://doi.org/10.1007/BF02015294
Issue Date:
DOI: https://doi.org/10.1007/BF02015294